Acquisitions · Cell therapy manufacturing
Hitachi Chemical buys cell therapy contract manufacturer PCT from Caladrius
- Buyer
- Hitachi Chemical (Tokyo)
- Target
- PCT LLC (from Caladrius Biosciences), Allendale, New Jersey
- Value
- About ¥8.7B
- Status
- Completed in 2017.
- Date
- 2017-03-17
Hitachi Chemical bought PCT, a contract manufacturer of cell therapies based in Allendale, New Jersey, from Caladrius Biosciences. The price was about ¥8.7 billion.
Why it matters
The deal gives Hitachi Chemical a US production base for cell therapies, a field where drug developers often rely on outside manufacturers.
Sources
Kakehashi M&A News home
